PRE dips as IM8 secures NBA nutrition partnership across nine markets and targets 660 million people
Market Chameleon (Mon, 12-Oct 7:58 AM ET)
IM8 Named Official Nutrition Partner of the NBA in Australia and Southeast Asia
Globe Newswire (Mon, 12-Oct 9:28 AM ET)
The Best Founders in America Oversubscribe Beanstalk 2026, Three Weeks Before Opening
Globe Newswire (Tue, 15-Sep 6:25 AM ET)
Globe Newswire (Wed, 26-Aug 8:38 AM ET)
Globe Newswire (Thu, 20-Aug 9:00 AM ET)
Market Chameleon (Tue, 18-Aug 5:42 AM ET)
Globe Newswire (Tue, 18-Aug 7:30 AM ET)
Globe Newswire (Mon, 17-Aug 8:30 AM ET)
Globe Newswire (Fri, 7-Aug 8:30 AM ET)
Prenetics' IM8 Secures $1 Billion Growth Financing from General Catalyst's Customer Value Fund (CVF)
Globe Newswire (Tue, 14-Jul 1:35 PM ET)
Prenetics Global Ltd is a consumer health and wellness company offering nutrition and longevity products through its flagship brand, IM8. It offers science-backed daily nutrition and longevity products distributed directly to consumers across multiple countries. The company's products are developed with scientific input and are subject to third-party quality certifications.
Prenetics Global Limited - Class A Ordinary Share trades on the NASDAQ stock market under the symbol PRE.
As of October 12, 2026, PRE stock price declined to $21.16 with 140,363 million shares trading.
PRE has a beta of 0.10, meaning it tends to be less sensitive to market movements. PRE has a correlation of 0.00 to the broad based SPY ETF.
PRE has a market cap of $355.05 million. This is considered a Small Cap stock.
Last quarter Prenetics Global Limited - Class A Ordinary Share reported $46 million in Revenue and -$.53 earnings per share. This fell short of revenue expectation by $-3 million and missed earnings estimates by -$.08.
In the last 3 years, PRE traded as high as $27.24 and as low as $2.85.
The top ETF exchange traded funds that PRE belongs to (by Net Assets): GWX.
PRE has outperformed the market in the last year with a return of +48.6%, while the SPY ETF gained +17.1%. In the last 3 month period, PRE beat the market returning +18.5%, while SPY returned +3.8%. However, in the most recent 2 weeks PRE has underperformed the stock market by returning -7.9%, while SPY returned +0.9%.
PRE support price is $20.70 and resistance is $22.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRE shares will trade within this expected range on the day.